VTIX is trading at $3.51 (5% up) in pre-market as the stock rebounds following news of a collaboration with Rutgers University for AI-assisted therapy.
- The initiative utilizes the Omni One VR platform to support therapy for neurodivergent children, highlighting a new AI-driven healthcare application for the company's technology.
- The move follows a period of heavy losses, with traders engaging in speculative buying after an 86% decline in share value.
- There are currently no new financial filings or earnings reports, suggesting the price action is driven primarily by the AI/healthcare narrative.